The 1.51-Å structure of the poxvirus L1 protein, a target of potent neutralizing antibodies

被引:62
|
作者
Su, HP
Garman, SC
Allison, TJ
Fogg, C
Moss, B
Garboczi, DN
机构
[1] NIAID, Struct Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA
[2] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[3] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA
关键词
myristoylation; virion protein; x-ray structure;
D O I
10.1073/pnas.0501103102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although eradicated from nature more than two decades ago, the threat of smallpox has reemerged because of concerns over its use as a biological weapon. We present the structure of the poxvirus L1 protein, a molecule that is conserved throughout the poxvirus family and is nearly identical in vaccinia virus and in variola virus, which causes smallpox. L1 is a myristoylated envelope protein that is a potent target for neutralizing antibodies and an important component of current experimental vaccines. The L1 structure reveals a hydrophobic cavity located adjacent to its N terminus. The cavity would be capable of shielding the myristate moiety, which is essential for virion assembly. The structure of L1 is a step in the elucidation of molecular mechanisms common to all poxviruses that may stimulate the design of safer vaccines and new antipoxvirus drugs.
引用
收藏
页码:4240 / 4245
页数:6
相关论文
共 50 条
  • [21] Structure of ribosomal protein L1 from Methanococcus thermolithotrophicus.: Functionally important structural invariants on the L1 surface
    Nevskaya, N
    Tishchenko, S
    Paveliev, M
    Smolinskaya, Y
    Fedorov, R
    Piendl, W
    Nakamura, Y
    Toyoda, T
    Garber, M
    Nikonov, S
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 : 1023 - 1029
  • [22] Designing a potent L1 protein-based HPV peptide vaccine: A bioinformatics approach
    Yazdani, Zahra
    Rafiei, Alireza
    Valadan, Reza
    Ashrafi, Hossein
    Pasandi, MarziehSharifi
    Kardan, Mostafa
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 85
  • [23] Potent and broadly neutralizing antibodies targeting HIV envelope protein gp120
    Song, Min
    FUTURE VIROLOGY, 2012, 7 (03) : 225 - 227
  • [24] A bioinformatics approach for identifying the probable cause of the cross-interaction of antibodies to the antigenic protein HPV16 L1 with the HPV6 L1 protein
    Stolbikov, A. S.
    Salyaev, R. K.
    Rekoslavskaya, N., I
    VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2021, 25 (07): : 787 - 792
  • [25] Towards an AIDS vaccine The transmembrane envelope protein as target for broadly neutralizing antibodies
    Denner, Joachim
    HUMAN VACCINES, 2011, 7 : 4 - 9
  • [26] Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae
    Kim, Hyoung Jin
    Lee, Seung Jae
    Kim, Hong-Jin
    JOURNAL OF BIOTECHNOLOGY, 2010, 150 (01) : 31 - 36
  • [27] Structure of the L1 protuberance in the ribosome
    Alexei Nikulin
    Irina Eliseikina
    Svetlana Tishchenko
    Natalia Nevskaya
    Natalia Davydova
    Olga Platonova
    Wolfgang Piendl
    Maria Selmer
    Anders Liljas
    Denis Drygin
    Robert Zimmermann
    Maria Garber
    Stanislav Nikonov
    Nature Structural Biology, 2003, 10 : 104 - 108
  • [28] Structure of the L1 protuberance in the ribosome
    Nikulin, A
    Eliseikina, I
    Tishchenko, S
    Nevskaya, N
    Davydova, N
    Platonova, O
    Piendl, W
    Selmer, M
    Liljas, A
    Drygin, D
    Zimmermann, R
    Garber, M
    Nikonov, S
    NATURE STRUCTURAL BIOLOGY, 2003, 10 (02) : 104 - 108
  • [29] Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies
    Day, Patricia M.
    Garnbhira, Ratish
    Roden, Richard B. S.
    Lowy, Douglas R.
    Schiller, John T.
    JOURNAL OF VIROLOGY, 2008, 82 (09) : 4638 - 4646
  • [30] GP120: Target for neutralizing HIV-1 antibodies
    Pantophlet, Ralph
    Burton, Dennis R.
    ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 739 - 769